Comments
Loading...
Novo Nordisk Earnings Estimates, EPS & Revenue | NYSE:NVO | Benzinga
Novo Nordisk reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$0.990
Quarterly Revenue Estimate
$11.67B
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$290.40B
Analyze the earnings history of Novo Nordisk using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO | Novo Nordisk | $0.83 | $0.99 | — | — | $9.52B | $11.67B | — | — | 05/07/2025 | Get Alert |
| NVO | Novo Nordisk | $0.71 | $0.83 | $0.91 | 9.64% | $11.77B | $11.34B | $12.26B | 8.10% | 02/05/2025 | Get Alert |
| NVO | Novo Nordisk | $0.73 | $0.88 | $0.90 | 2.27% | $8.58B | $10.49B | $10.50B | 0.13% | 11/06/2024 | Get Alert |
| NVO | Novo Nordisk | $0.63 | $0.69 | $0.65 | -5.80% | $7.94B | $9.97B | $9.82B | -1.49% | 08/07/2024 | Get Alert |
| NVO | Novo Nordisk | $0.64 | $0.74 | $0.83 | 12.16% | $7.69B | $9.07B | $9.52B | 4.93% | 05/02/2024 | Get Alert |
| NVO | Novo Nordisk | $0.41 | $0.65 | $0.71 | 9.08% | $6.44B | $8.82B | $9.50B | 7.75% | 01/31/2024 | Get Alert |
| NVO | Novo Nordisk | $0.43 | $0.71 | $0.73 | 2.82% | $6.17B | $7.91B | $8.58B | 8.42% | 11/02/2023 | Get Alert |
| NVO | Novo Nordisk | $0.42 | $0.64 | $0.63 | -1.56% | $5.91B | $7.97B | $7.94B | -0.39% | 08/10/2023 | Get Alert |
| NVO | Novo Nordisk | $0.47 | $0.64 | $0.64 | 0.00% | $6.34B | $7.65B | $7.69B | 0.55% | 05/04/2023 | Get Alert |
| NVO | Novo Nordisk | $0.37 | $0.43 | $0.41 | -4.65% | $5.90B | $6.84B | $6.44B | -5.91% | 02/01/2023 | Get Alert |
| NVO | Novo Nordisk | $0.42 | $0.42 | $0.43 | 2.38% | $5.64B | $5.89B | $6.17B | 4.82% | 11/02/2022 | Get Alert |
| NVO | Novo Nordisk | $0.43 | $0.41 | $0.42 | 2.44% | $5.32B | $5.81B | $5.91B | 1.76% | 08/03/2022 | Get Alert |
| NVO | Novo Nordisk | $0.44 | $0.40 | $0.47 | 17.50% | $5.48B | $5.59B | $6.34B | 13.43% | 04/29/2022 | Get Alert |
| NVO | Novo Nordisk | $0.32 | $0.36 | $0.37 | 2.78% | $5.14B | $5.67B | $5.90B | 3.99% | 02/02/2022 | Get Alert |
| NVO | Novo Nordisk | $0.35 | $0.39 | $0.42 | 7.69% | $4.86B | $5.35B | $5.64B | 5.51% | 11/03/2021 | Get Alert |
| NVO | Novo Nordisk | $0.34 | $0.39 | $0.43 | 10.26% | $4.43B | $5.11B | $5.32B | 4.15% | 08/05/2021 | Get Alert |
| NVO | Novo Nordisk | $0.38 | $0.42 | $0.44 | 4.76% | $5.08B | $5.29B | $5.48B | 3.59% | 05/05/2021 | Get Alert |
| NVO | Novo Nordisk | $0.28 | $0.32 | $0.32 | 0.00% | $4.86B | $5.35B | $5.14B | -3.89% | 02/03/2021 | Get Alert |
| NVO | Novo Nordisk | $0.32 | $0.36 | $0.35 | -2.78% | $4.54B | $4.89B | $4.86B | -0.70% | 10/30/2020 | Get Alert |
| NVO | Novo Nordisk | $0.31 | — | $0.34 | — | $4.51B | — | $4.43B | — | 08/06/2020 | Get Alert |
| NVO | Novo Nordisk | $0.33 | — | $0.38 | — | $4.39B | — | $5.08B | — | 05/06/2020 | Get Alert |
Novo Nordisk (NVO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-05 | $0.91 | $0.83 | 9.64 % |
| Q3 | 2024-11-06 | $0.90 | $0.88 | 2.27 % |
| Q2 | 2024-08-07 | $0.65 | $0.69 | -5.80 % |
| Q1 | 2024-05-02 | $0.83 | $0.74 | 12.2 % |
Novo Nordisk (NVO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-05 | $12.26B | $11.34B | 8.10 % |
| Q3 | 2024-11-06 | $10.50B | $10.49B | 0.13 % |
| Q2 | 2024-08-07 | $9.82B | $9.97B | -1.49 % |
| Q1 | 2024-05-02 | $9.52B | $9.07B | 4.93 % |
FAQ
When is Novo Nordisk (NYSE:NVO) reporting earnings?
Novo Nordisk (NVO) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on February 5, 2025 for Q4.
What were the latest earnings per share (EPS) for Novo Nordisk (NYSE:NVO)?
The Actual EPS was $0.91, which beat the estimate of $0.83.
What were Novo Nordisk’s (NYSE:NVO) revenues?
The Actual Revenue was $12.3B, which beat the estimate of $11.3B.
Browse earnings estimates, EPS, and revenue on all stocks.